$MEDBOT-B (02252.HK)$ Personal View of minimally invasive ro...

Several key points, not profitable, High ling IPO increase, JPMORGAN Chase sponsor, expected 50% callback, IPO for the previous investment rise range is still ok, speculation new mood has not recovered;

In summary, in terms of playing new, the probability of winning is almost 50/50, the odds are not high, if the call back to break the resistance to save slightly bigger